Table 2:
Product, Method of Use, and Bioavailability | Onset and Duration of Effect | Advantages | Disadvantages |
---|---|---|---|
Combustible flower: usually smoked rolled in paper or in a pipe. • Bioavailability: Varies between10–35% due to difference in number of breaths, duration of puff, breath holding, inhalation volume.26 |
• Onset: 3–10 minutes26 • Duration: ≤2 hours99 |
• Quick onset of action | Potential for adverse effects (short- and long-term): • Intoxication68 • Chronic bronchitis60 |
Vaped oil: Inhaled using a battery-operated portable pen-like device • Bioavailability: Varies between 2% to 56% due to difference in smoking dynamics (number of puffs, spacing of puffs, hold time, inhalation time, etc.) 99 |
• Peak: 9 minutes99 • Duration: ≤2 hours99 |
• Quick onset of action | Potential for adverse effects (short- and long-term): • Intoxication68 • Chronic bronchitis60 • Vaping lung injury (vitamin E acetate additive) 84 |
Vaped ground flower pods: Inhaled using a unique table-top device that creates vapor from plant material • Bioavailability: Varies between 2% to 56% due to difference in smoking dynamics (number of puffs, spacing of puffs, hold time, inhalation time, etc.) 99 |
• Peak: 9 minutes99 • Duration: ≤2 hours99 |
• Quick onset of action | Potential for adverse effects (short- and long-term): • Intoxication68 • Chronic bronchitis60 |
Capsule: Oral ingestion • Bioavailability: 4% to 25% depending upon the study. 63–67 Variable due to drug degradation in stomach, variable absorption in the stomach, and first-pass metabolism |
• Peak: 1–5 hours63–67 • Duration: ≤25 hours63–67 |
• Slow onset of action, low bioavailability • Avoid adverse effects of smoking |
• Risk of dose stacking—repeating doses before an effect is felt by the patient. Usually attributable to a long period before onset of effect. Results in unanticipated intoxication and adverse effects68,69 |
Tincture and spray: Sublingual/oral • Bioavailability: 87.5% to 90%100,101 |
• Onset: As early as 10 min100–102 • Duration: ≤10 hours100,101 |
• Fast onset of action • Avoid adverse effects of smoking |
• Taste • Potential for user error |
Suppository: Rectal • Bioavailability: 14% to 67% 22,103 |
• Onset: 1–2 hours104 • Duration: ≤8 hours104 |
• Avoid first-pass effect104 • Avoid adverse effects of smoking |
• Undesirable dosing method • Very little supporting data for the use of suppositories |
Lotions, gels: Transdermal • Bioavailability: Dependent upon how it is formulated, only studied in animal models22 |
• Onset: 2 hours105 • Duration: ≤48 hours105 |
• Avoid adverse effects of smoking • Helpful in patients unable to adhere to other formulations (terminal illness, etc.) |
• Variability of bioavailability depending on how it is formulated105 |